It’s time we talked about biopharma — live in London next week
Zoom can only go so far. And I think at this stage, we’ve all tested the limits of staying in touch — virtually. So I’m particularly happy now that we’ve revved up the travel machine to point myself to London for the first time in several years.
Whatever events we have lined up, we’ve always built in plenty of opportunities for all of us to get together and talk. For London, live, I plan to be right out front, meeting with and chatting with the small crowd of biopharma people we are hosting on October 12 at Silicon Valley Bank’s London headquarters. And there’s a lengthy mixer at the end I’m most looking forward to, with several networking openings between sessions.
This lineup is part of a slate of virtual and live/streaming events coming up on October 12, with fireside chats and some roundtable discussions covering the cutting-edge work going on in Europe around mRNA and cell therapies. Going live in the afternoon, BST, I’ll be sitting down with AstraZeneca’s Susan Galbraith for a discussion covering her management style and strategy at the pharma giant. And I’ll be talking with an interesting group of biotech CEOs — Adrian Rawcliffe, Kate Bingham, Andrew Hopkins and Denise Scots-Knight — about surviving one of the craziest years we’ve ever seen on the public market.
Nooman Haque, my co-host for the day’s events, will wrap things up with a results-oriented look at financing in this market. And we’ll wrap it all up with drinks and a mixer at the end, on SVB’s balcony. It’s one of the best views in town.
I hope to see you there. Drop me a line if you have any questions. And be sure to sign up today, right here.